UBT251 Injection Phase II Clinical Study (CKD)

Abroad (travel likely)RecruitingPHASE2

Conditions

Obesity &Amp; Overweight · Chronic Kidney Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Peking University First Hospital, Beijing, China
Contact: Study coordinator (Minghui Zhao) · mhzhao@bjmu.edu.cn · 13501243815
Contact: Study coordinator (Min Chen) · chenmin74@sina.com · 13621314283

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Assessment and Management of Multiple Drug Use in Elderly Chronic Disease Patients

Coronary Artery Disease · Diabete Mellitus · Chronic Kidney Disease

Abroad (travel likely)Recruiting

Xi'an, China

Phase 1/2a Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effect on Body Weight of RN3161 as Monotherapy and in Combination With Tirzepatide in Adults With Overweight and Obesity

Obesity &Amp; Overweight

Abroad (travel likely)RecruitingPHASE1, PHASE2

Melbourne, Australia

Studying the Influence of LEAP2 on Integrated Endocrine Control of Eating During Semaglutide Treatment

Obesity &Amp; Overweight

Abroad (travel likely)RecruitingPHASE1, PHASE2

Hellerup, Denmark

Effect of Nicotinamide Riboside on Ketosis, Fat Oxidation & Metabolic Rate

Overweight · Obesity

Abroad (travel likely)Recruiting

Bethesda, United States